Takeda Pharmaceuticals and Indian vaccine manufacturer Biological E have announced a partnership to facilitate access to QDENGA, Takeda's tetravalent dengue vaccine. [Live, Attenuated]) (TAK-003) Multi-dose vial....
The vaccine, TAK-003, has been approved by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the prevention of...
London (AP) — European Union drug regulators said they received an application from Novabax to authorize a coronavirus vaccine from a US biotechnology company. Sources 1/...
Takeda Pharmaceutical Co., Ltd., a Japanese pharmaceutical company, announced that TAK-003, a candidate for dengue vaccine, has shown continuous protection for three years after vaccination, regardless...
Recent Comments